Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders
J. Schimmelpfennig, Kamila Jankowiak-Siuda
Pharmacotherapy in Psychiatry and Neurology January 1, 2023 Peer reviewed DOI: 10.5114/fpn.2023.131979 via OpenAlex
Summary
N,N-dimethyltryptamine (DMT) shows potential as a treatment for various psychiatric and neurodegenerative disorders. The review discusses how DMT may impact conditions like depression, anxiety, and neurodegeneration by interacting with specific receptors in the brain. However, the abstract does not provide specific results or data from studies to support these claims.
Study at a glance
| Design | review |
|---|---|
| Key finding | DMT may have therapeutic potential for treating psychiatric and neurodegenerative disorders. |
Abstract
AMA Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(2), 115-130. https://doi.org/10.5114/fpn.2023.131979 Chicago Schimmelpfennig, Jakub, and Kamila Jankowiak-Siuda. 2023. "Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 39 (2): 115-130. doi:10.5114/fpn.2023.131979. Harvard Schimmelpfennig, J., and Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(2), pp.115-130. https://doi.org/10.5114/fpn.2023.131979 MLA Schimmelpfennig, Jakub et al. "Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 39, no. 2, 2023, pp. 115-130. doi:10.5114/fpn.2023.131979. Vancouver Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979.